Gedeon Richter’s once-daily endometriosis pill approved for NHS use
The UK’s National Institute for Health and Care (NICE) has approved Gedeon Richter’s Ryeqo (relugolix–estradiol–norethisterone), a once-daily oral treatment for …
Post
-
-
Mallinckrodt and Endo sign $6.7bn merger deal
Mallinckrodt Pharmaceuticals and Endo have agreed to merge in a $6.7bn deal, combining two pharmaceutical companies that recently emerged from …
-
Vivani treats first patient with long-lasting drug implant for weight loss
A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the …
-
Emergent signs financial investment agreement with Swiss Rockets
Emergent BioSolutions has entered a strategic financial investment agreement with Swiss Rockets to support infrastructure development, research and the expansion …
-
Telix’s new lead-212 generator could dispel medical isotope scalability hurdles
Australia-based radiopharmaceutical company Telix Pharmaceuticals has created a new radionuclide generator that could facilitate the commercial supply of lead-212 isotope-based …
-
Vivace closes $35m in Series D for cancer drug development
Vivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug …
-
Atsena’s ATSN-201 gains FDA fast track status for XLRS treatment
Atsena Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for its gene therapy product …
-
Orphelia explores avenues for liquid neuroblastoma med after EU CHMP rejection
Orphelia Pharma is exploring alternative regulatory pathways for Kizfizo (temozolomide) following a negative opinion from the European Medicines Agency’s (EMA) …
-
Ono earmarks $940m to gain rare blood cancer therapy from Ionis
Japan-based Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy developed by Ionis Pharmaceuticals for the treatment …
-
Envirotainer expands cold chain solutions portfolio to cover all pharma segments, sizes and temperatures
Envirotainer, the specialist in temperature-sensitive pharmaceutical shipments, is introducing the industry’s most comprehensive cold chain portfolio, enabling pharmaceutical companies to …
-
Vori Health secures $53m funding to support musculoskeletal care
Vori Health has secured $53m in a Series B funding round, supporting its value-based musculoskeletal care offerings in the US. New …
-
Zealand and Roche strike $5.3bn obesity treatment deal
Zealand Pharma has named Roche as a development and commercialisation partner for its lead obesity candidate petrelintide, after a seven-month …
-
Canada and Alberta governments to invest in Entos R&D facility
Entos Pharmaceuticals has announced an investment of C$62m ($43.05m) from the government of Canada, further leveraging C$15.5m previously announced by …
-
WuXi XDC and AbTis collaborate on antibody-drug conjugates
Contract research, development and manufacturing organisation (CRDMO) WuXi XDC Cayman has signed a memorandum of understanding with South Korea-based AbTis …
-
BMS to acquire longtime cell therapy partner 2seventy bio for $286m
Bristol Myers Squibb (BMS) has agreed to acquire its longtime cell therapy partner 2seventy bio in a deal valued at …
